Selected research
Industry Research
Elisa Development and Test Industry Research Report 2026
Market perspective
The global Elisa Development and Test market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Elisa Development and Test market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Elisa Development and Test market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Elisa Development and Test market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Elisa Development and Test include Aviva Systems Biology, GTP Bioways, Thermo Fisher Scientific, Charles River, Bio-Techne, Biorbyt, STEFFENS BIOTEC, ARVYS Proteins and QED Bioscience and among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Elisa Development and Test market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Elisa Development and Test.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Elisa Development and Test Market by Company
Aviva Systems Biology
GTP Bioways
Thermo Fisher Scientific
Charles River
Bio-Techne
Biorbyt
STEFFENS BIOTEC
ARVYS Proteins
QED Bioscience
Capra Science Antibodies AB
Elisa Development and Test Segment by Type
Elisa Development
Elisa Test
Elisa Development and Test Segment by Application
Biotechnology
Laboratory
Others
Elisa Development and Test Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Elisa Development and Test market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Elisa Development and Test and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Elisa Development and Test.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Elisa Development and Test companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Elisa Development
- Elisa Test
Applications
- Biotechnology
- Laboratory
- Others
Companies covered
- Aviva Systems Biology
- GTP Bioways
- Thermo Fisher Scientific
- Charles River
- Bio-Techne
- Biorbyt
- STEFFENS BIOTEC
- ARVYS Proteins
- QED Bioscience
- Capra Science Antibodies AB
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Elisa Development and Test by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Elisa Development
- 2.2.3 Elisa Test
- 2.3 Elisa Development and Test by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Biotechnology
- 2.3.3 Laboratory
- 2.3.4 Others
- 2.4 Assumptions and Limitations
3 Elisa Development and Test Breakdown Data by Type
- 3.1 Global Elisa Development and Test Historic Market Size by Type (2021-2026)
- 3.2 Global Elisa Development and Test Forecasted Market Size by Type (2027-2032)
4 Elisa Development and Test Breakdown Data by Application
- 4.1 Global Elisa Development and Test Historic Market Size by Application (2021-2026)
- 4.2 Global Elisa Development and Test Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Elisa Development and Test Market Perspective (2021-2032)
- 5.2 Global Elisa Development and Test Growth Trends by Region
- 5.2.1 Global Elisa Development and Test Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Elisa Development and Test Historic Market Size by Region (2021-2026)
- 5.2.3 Elisa Development and Test Forecasted Market Size by Region (2027-2032)
- 5.3 Elisa Development and Test Market Dynamics
- 5.3.1 Elisa Development and Test Industry Trends
- 5.3.2 Elisa Development and Test Market Drivers
- 5.3.3 Elisa Development and Test Market Challenges
- 5.3.4 Elisa Development and Test Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Elisa Development and Test Players by Revenue
- 6.1.1 Global Top Elisa Development and Test Players by Revenue (2021-2026)
- 6.1.2 Global Elisa Development and Test Revenue Market Share by Players (2021-2026)
- 6.2 Global Elisa Development and Test Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Elisa Development and Test Head Office and Area Served
- 6.4 Global Elisa Development and Test Players, Product Type & Application
- 6.5 Global Elisa Development and Test Manufacturers Established Date
- 6.6 Global Elisa Development and Test Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Elisa Development and Test Market Size (2021-2032)
- 7.2 North America Elisa Development and Test Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Elisa Development and Test Market Size by Country (2021-2026)
- 7.4 North America Elisa Development and Test Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Elisa Development and Test Market Size (2021-2032)
- 8.2 Europe Elisa Development and Test Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Elisa Development and Test Market Size by Country (2021-2026)
- 8.4 Europe Elisa Development and Test Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Elisa Development and Test Market Size (2021-2032)
- 9.2 Asia-Pacific Elisa Development and Test Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Elisa Development and Test Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Elisa Development and Test Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Elisa Development and Test Market Size (2021-2032)
- 10.2 South America Elisa Development and Test Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Elisa Development and Test Market Size by Country (2021-2026)
- 10.4 South America Elisa Development and Test Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Elisa Development and Test Market Size (2021-2032)
- 11.2 Middle East & Africa Elisa Development and Test Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Elisa Development and Test Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Elisa Development and Test Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Aviva Systems Biology
- 12.1.1 Aviva Systems Biology Company Information
- 12.1.2 Aviva Systems Biology Business Overview
- 12.1.3 Aviva Systems Biology Revenue in Elisa Development and Test Business (2021-2026)
- 12.1.4 Aviva Systems Biology Elisa Development and Test Product Portfolio
- 12.1.5 Aviva Systems Biology Recent Developments
- 12.2 GTP Bioways
- 12.2.1 GTP Bioways Company Information
- 12.2.2 GTP Bioways Business Overview
- 12.2.3 GTP Bioways Revenue in Elisa Development and Test Business (2021-2026)
- 12.2.4 GTP Bioways Elisa Development and Test Product Portfolio
- 12.2.5 GTP Bioways Recent Developments
- 12.3 Thermo Fisher Scientific
- 12.3.1 Thermo Fisher Scientific Company Information
- 12.3.2 Thermo Fisher Scientific Business Overview
- 12.3.3 Thermo Fisher Scientific Revenue in Elisa Development and Test Business (2021-2026)
- 12.3.4 Thermo Fisher Scientific Elisa Development and Test Product Portfolio
- 12.3.5 Thermo Fisher Scientific Recent Developments
- 12.4 Charles River
- 12.4.1 Charles River Company Information
- 12.4.2 Charles River Business Overview
- 12.4.3 Charles River Revenue in Elisa Development and Test Business (2021-2026)
- 12.4.4 Charles River Elisa Development and Test Product Portfolio
- 12.4.5 Charles River Recent Developments
- 12.5 Bio-Techne
- 12.5.1 Bio-Techne Company Information
- 12.5.2 Bio-Techne Business Overview
- 12.5.3 Bio-Techne Revenue in Elisa Development and Test Business (2021-2026)
- 12.5.4 Bio-Techne Elisa Development and Test Product Portfolio
- 12.5.5 Bio-Techne Recent Developments
- 12.6 Biorbyt
- 12.6.1 Biorbyt Company Information
- 12.6.2 Biorbyt Business Overview
- 12.6.3 Biorbyt Revenue in Elisa Development and Test Business (2021-2026)
- 12.6.4 Biorbyt Elisa Development and Test Product Portfolio
- 12.6.5 Biorbyt Recent Developments
- 12.7 STEFFENS BIOTEC
- 12.7.1 STEFFENS BIOTEC Company Information
- 12.7.2 STEFFENS BIOTEC Business Overview
- 12.7.3 STEFFENS BIOTEC Revenue in Elisa Development and Test Business (2021-2026)
- 12.7.4 STEFFENS BIOTEC Elisa Development and Test Product Portfolio
- 12.7.5 STEFFENS BIOTEC Recent Developments
- 12.8 ARVYS Proteins
- 12.8.1 ARVYS Proteins Company Information
- 12.8.2 ARVYS Proteins Business Overview
- 12.8.3 ARVYS Proteins Revenue in Elisa Development and Test Business (2021-2026)
- 12.8.4 ARVYS Proteins Elisa Development and Test Product Portfolio
- 12.8.5 ARVYS Proteins Recent Developments
- 12.9 QED Bioscience
- 12.9.1 QED Bioscience Company Information
- 12.9.2 QED Bioscience Business Overview
- 12.9.3 QED Bioscience Revenue in Elisa Development and Test Business (2021-2026)
- 12.9.4 QED Bioscience Elisa Development and Test Product Portfolio
- 12.9.5 QED Bioscience Recent Developments
- 12.10 Capra Science Antibodies AB
- 12.10.1 Capra Science Antibodies AB Company Information
- 12.10.2 Capra Science Antibodies AB Business Overview
- 12.10.3 Capra Science Antibodies AB Revenue in Elisa Development and Test Business (2021-2026)
- 12.10.4 Capra Science Antibodies AB Elisa Development and Test Product Portfolio
- 12.10.5 Capra Science Antibodies AB Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst